Intellectual Property protection with international patent demand n° PCT/EP2013/

Patent of “Variant of BPIFB4 protein”

We have covered most of the potential applications of the BPIFB4 protein with a degree of degeneration, or its fragment, as well as DNA and its fragment for the cure of

arterial hypertension, atherosclerosis, diabetes mellitus, dyslipidaemia, renal failure, metabolic syndrome, stroke, myocardial infarction, erectile dysfunction, neurodegenerative diseases, multiple sclerosis, cognitive disorders retinal degeneration, uveoretinitis, vascular retinopathy, cataract, glaucoma, coronary spastic angina, thrombosis, pulmonary hypertension, pre-eclampsia, vasculites, cancer, inflammatory disorders, venus insufficiency, genetic diseases.


Lgv1 submitted the applications in Canada, USA, Australia, Europe, Japan, and Cina.